{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-1978-N-1446\" sorted by posted_date descending", "rows": [["FDA-1978-N-1446-0036", "FDA", "FDA-1978-N-1446", "Reference A Rorer Research Monograph Emetrol re: Supplement from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T16:06:25Z", null, 0, 0, "0900006482054511"], ["FDA-1978-N-1446-0037", "FDA", "FDA-1978-N-1446", "Reference C Federal Register Notices Vol. 40 No. 56 pg 12937 March 21, 1975 and Vol. 44 No. 136 pg 41071 July 13, 1979 re: Supplement from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T16:10:01Z", null, 0, 0, "0900006482054513"], ["FDA-1978-N-1446-0038", "FDA", "FDA-1978-N-1446", "Reference D Physicians' Desk Reference re: Supplement from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T16:11:04Z", null, 0, 0, "0900006482054514"], ["FDA-1978-N-1446-0039", "FDA", "FDA-1978-N-1446", "Reference E Product Information on Emetrol re: Supplement from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T16:12:24Z", null, 0, 0, "0900006482054515"], ["FDA-1978-N-1446-0018", "FDA", "FDA-1978-N-1446", "Tab 2 Statement of the Regulatory Analysis Assessment of the Tentative Order for a Monograph for OTC Antiemetic Drug Products re: Antiemetic TFM Administrative Record (78N-0036) 44FR41064", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:46:28Z", null, 0, 0, "0900006482057857"], ["FDA-1978-N-1446-0041", "FDA", "FDA-1978-N-1446", "Memorandum from OTC Drug Evaluation (CDER) to DDM", "Other", "Memorandum", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T16:26:12Z", null, 0, 0, "090000648059b3eb"], ["FDA-1978-N-1446-0028", "FDA", "FDA-1978-N-1446", "Letter from William H. Rorer, Inc. to OTC Drug Evaluation (CDER)", "Other", "Letter(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T15:20:29Z", null, 0, 0, "090000648059b3e7"], ["FDA-1978-N-1446-0025", "FDA", "FDA-1978-N-1446", "Objection from Environmental Defense Fund and Public Citizen Health Research Group", "Other", "Objection(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T15:08:14Z", null, 0, 0, "090000648059b3e3"], ["FDA-1978-N-1446-0024", "FDA", "FDA-1978-N-1446", "Objection and Request for Hearing from Norwich-Eaton Pharmaceuticals", "Other", "Objection(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T15:01:51Z", null, 0, 0, "090000648059b3e2"], ["FDA-1978-N-1446-0042", "FDA", "FDA-1978-N-1446", "Letter from OTC Drug Evaluation (CDER) to William H. Rorer, Inc.", "Other", "Letter(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T16:28:57Z", null, 0, 0, "090000648059b3ee"], ["FDA-1978-N-1446-0016", "FDA", "FDA-1978-N-1446", "Table of Contents Antiemetic TFM Administrative Record (78N-0036)", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:36:49Z", null, 0, 0, "090000648059b3f6"], ["FDA-1978-N-1446-0050", "FDA", "FDA-1978-N-1446", "Memorandum of Telephone Conversation between William H. Rorer, Inc. and OTC Drug Evaluation (CDER)", "Other", "Memorandum", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T19:09:48Z", null, 0, 0, "090000648059b3f4"], ["FDA-1978-N-1446-0047", "FDA", "FDA-1978-N-1446", "Memorandum of Telephone Conversation between William H. Rorer, Inc. and FDA", "Other", "Memorandum", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T18:43:39Z", null, 0, 0, "090000648059b3f1"], ["FDA-1978-N-1446-0032", "FDA", "FDA-1978-N-1446", "Attachment 2 Consumer Survey on Symptoms of Upset Stomach re: Comment from Norwich-Eaton Pharmaceuticals", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T15:39:28Z", null, 0, 0, "0900006482053dad"], ["FDA-1978-N-1446-0045", "FDA", "FDA-1978-N-1446", "Table of Contents re: Citizen Petition from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T18:40:33Z", null, 0, 0, "0900006482058041"], ["FDA-1978-N-1446-0027", "FDA", "FDA-1978-N-1446", "Attachment 8 Studies in Motion Sickness as Related to Commercial Aviation Aero Medical Association May 14-17, 1951 re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T15:14:19Z", null, 0, 0, "0900006482050d22"], ["FDA-1978-N-1446-0046", "FDA", "FDA-1978-N-1446", "Certification Statement from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T18:41:44Z", null, 0, 0, "090000648059b3f0"], ["FDA-1978-N-1446-0021", "FDA", "FDA-1978-N-1446", "Tab 5 Memorandum of Telephone Conversation (July 2,  1978) between Ronald F. Panner (William H. Rorer, Inc.) and FDA re: Antiemetic TFM Administrative Record (78N-0036) 44FR41064", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:49:08Z", null, 0, 0, "090000648205785a"], ["FDA-1978-N-1446-0040", "FDA", "FDA-1978-N-1446", "Memorandum of Telephone Conference between FDA and William H. Rorer, Inc.,", "Other", "Memorandum", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T16:24:12Z", null, 0, 0, "090000648059b3ea"], ["FDA-1978-N-1446-0022", "FDA", "FDA-1978-N-1446", "Objection from William H. Rorer Inc.,", "Other", "Objection(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T14:57:10Z", null, 0, 0, "090000648059b3e0"], ["FDA-1978-N-1446-0015", "FDA", "FDA-1978-N-1446", "Memorandum from OTC Drug Evaluation (CDER) to Dockets", "Other", "Memorandum", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T14:35:13Z", null, 0, 0, "090000648205733c"], ["FDA-1978-N-1446-0033", "FDA", "FDA-1978-N-1446", "Supplement from William H. Rorer, Inc.", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T16:00:53Z", null, 0, 0, "090000648059b3ed"], ["FDA-1978-N-1446-0031", "FDA", "FDA-1978-N-1446", "Attachment 1 Part 336 Antiemetic, Antinauseant Drug Products for Over-the-Counter Human Use re: Comment from Norwich-Eaton Pharmaceuticals", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T15:38:01Z", null, 0, 0, "0900006482053dac"], ["FDA-1978-N-1446-0019", "FDA", "FDA-1978-N-1446", "Tab 3  Statement of Exemption and Environmental Assessment Report for the Establishment of a Tentative Final Monograph for OTC Antiemetic Drug Products re: Antiemetic TFM Administrative Record (78N-0036) 44FR41064", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:47:18Z", null, 0, 0, "0900006482057858"], ["FDA-1978-N-1446-0051", "FDA", "FDA-1978-N-1446", "Antiemetic Drug Products for Over-the-Counter Human Use; Final Monograph", "Notice", "Notice of Final Rule", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", "1988-05-03T03:59:59Z", "2016-06-30T19:11:42Z", null, 0, 0, "090000648059b3f5"], ["FDA-1978-N-1446-0043", "FDA", "FDA-1978-N-1446", "Citizen Petition from William H. Rorer, Inc.", "Other", "Citizen Petition", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T16:33:49Z", null, 0, 0, "090000648059b3ef"], ["FDA-1978-N-1446-0029", "FDA", "FDA-1978-N-1446", "Answer from FDA OTC Drug Evaluation (CDER) to William H. Rorer, Inc.,", "Other", "Answer", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T15:28:41Z", null, 0, 0, "0900006482051eb7"], ["FDA-1978-N-1446-0048", "FDA", "FDA-1978-N-1446", "Petition Approval Letter from FDA OC to William H. Rorer, Inc.", "Other", "Approval", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T18:53:10Z", null, 0, 0, "090000648059b3f2"], ["FDA-1978-N-1446-0049", "FDA", "FDA-1978-N-1446", "Letter from FDA OTC Drug Evaluation (CDER) to William H. Rorer, Inc.", "Other", "Letter(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T18:55:33Z", null, 0, 0, "090000648059b3f3"], ["FDA-1978-N-1446-0020", "FDA", "FDA-1978-N-1446", "Tab 4 Letter (December 29, 1977) from N. D. Hightower, \nM.D. to FDA re: Antiemetic TFM Administrative Record (78N-0036) 44FR41064", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:48:11Z", null, 0, 0, "0900006482057859"], ["FDA-1978-N-1446-0044", "FDA", "FDA-1978-N-1446", "Acknowledgment Letter from FDA DDM to William H. Rorer, Inc.", "Other", "Acknowledgement Letter/Receipt", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T16:45:30Z", null, 0, 0, "0900006482058680"], ["FDA-1978-N-1446-0023", "FDA", "FDA-1978-N-1446", "Objection from Searle Lab Inc.,", "Other", "Objection(s)", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T15:00:30Z", null, 0, 0, "090000648059b3e1"], ["FDA-1978-N-1446-0026", "FDA", "FDA-1978-N-1446", "Memorandum of Telephone Conversation between William H. Rohrer, Inc. and OTC Drug Evaluation (CDER)", "Other", "Memorandum", "2016-06-30T04:00:00Z", 2016, 6, "2016-06-30T04:00:00Z", null, "2016-06-30T15:10:12Z", null, 0, 0, "090000648059b3e6"], ["FDA-1978-N-1446-0034", "FDA", "FDA-1978-N-1446", "Table of Contents Appendices A-D re: Comment from Norwich-Eaton Pharmaceuticals", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T15:49:24Z", null, 0, 0, "0900006482053e53"], ["FDA-1978-N-1446-0035", "FDA", "FDA-1978-N-1446", "Introduction re: Comment from Norwich-Eaton Pharmaceuticals", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T15:50:09Z", null, 0, 0, "0900006482053e54"], ["FDA-1978-N-1446-0017", "FDA", "FDA-1978-N-1446", "Tab 1 Minutes of the Seventh Meeting of the Neurologic Drugs Advisory Committee (June 27-28,1977) re: Antiemetic TFM Administrative Record (78N-0036) 44FR41064", "Supporting & Related Material", "Background Material", "2016-06-30T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:45:14Z", null, 0, 0, "0900006482057856"], ["FDA-1978-N-1446-0008", "FDA", "FDA-1978-N-1446", "Attachment 5 Chinn, Noell and Smith Prophylaxis of Motion Sickness Arch. Int. Med. 86: pgs 810-822 Dec. 1950 re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T19:02:34Z", null, 0, 0, "0900006482050b87"], ["FDA-1978-N-1446-0005", "FDA", "FDA-1978-N-1446", "Attachment 2 Federal Register Notice Drugs for Human Use; Drug Efficacy Study Implementation re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T18:59:03Z", null, 0, 0, "0900006482050744"], ["FDA-1978-N-1446-0009", "FDA", "FDA-1978-N-1446", "Attachment 6 Report of Study by Army, Navy, Air Force Motion Sickness Team Evaluation of Drugs for Protection Against Motion Sickness aborad Transport Ships pgs. 755-760 re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T19:03:34Z", null, 0, 0, "0900006482050b8b"], ["FDA-1978-N-1446-0014", "FDA", "FDA-1978-N-1446", "Animal Safety Study/Report from Commerce Drug Co. Inc., (McMurray and Pendergast) re: Acute Oral Toxiciity", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-30T14:17:54Z", null, 0, 0, "090000648059b3dd"], ["FDA-1978-N-1446-0007", "FDA", "FDA-1978-N-1446", "Attachment 4 Gay and Carliner The Prevention and Treatment of  Motion Sickness pgs. 470-487 John Hopkins Hosp. re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T19:01:43Z", null, 0, 0, "0900006482050b84"], ["FDA-1978-N-1446-0004", "FDA", "FDA-1978-N-1446", "Attachment 1 Letters of Support to Searle Laboratories re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T18:58:02Z", null, 0, 0, "0900006482050743"], ["FDA-1978-N-1446-0013", "FDA", "FDA-1978-N-1446", "Antiemetic Drug Products for Over-the-Counter Human Use; Tentative Final Order", "Notice", "Notice of Tentative Final Order", "2016-06-29T04:00:00Z", 2016, 6, "1979-07-13T04:00:00Z", "1979-08-14T03:59:59Z", "2016-07-09T20:29:50Z", "1979-21600", 0, 0, "090000648059b3d3"], ["FDA-1978-N-1446-0006", "FDA", "FDA-1978-N-1446", "Attachment 3 Letter from Federal Security Agency (FDA) to G.D. Searle and Company re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T19:00:26Z", null, 0, 0, "0900006482050b34"], ["FDA-1978-N-1446-0001", "FDA", "FDA-1978-N-1446", "Proposal to Establish Monographs for OTC Laxative, Antidiarrheal, Emetic, and Antiemetic Products", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2016-06-29T04:00:00Z", 2016, 6, "1975-03-21T04:00:00Z", "1975-04-21T03:59:59Z", "2016-07-01T01:00:43Z", null, 0, 0, "09000064820500d4"], ["FDA-1978-N-1446-0010", "FDA", "FDA-1978-N-1446", "Attachment 9 Acknowledgment Letter from FDA to Searle Laboratories re: Comment from Searle Lab, Inc.", "Supporting & Related Material", "Background Material", "2016-06-29T04:00:00Z", 2016, 6, null, null, "2016-06-29T19:05:41Z", null, 0, 0, "0900006482050d25"], ["FDA-1978-N-1446-0011", "FDA", "FDA-1978-N-1446", "Amendment from Searle Labs, Inc.", "Other", "Amendment", "2016-06-29T04:00:00Z", 2016, 6, "2016-06-29T04:00:00Z", null, "2016-06-29T19:07:14Z", null, 0, 0, "090000648059b3db"]], "truncated": false, "filtered_table_rows_count": 47, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1978-N-1446"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446", "results": [{"value": "FDA", "label": "FDA", "count": 47, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-1446", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&document_type=Notice", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446", "results": [{"value": 2016, "label": 2016, "count": 47, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&posted_year=2016", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet=posted_date"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-1446&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 48.77860296983272, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}